316
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Sustained-release alginate-chitosan pellets prepared by melt pelletization technique

&
Pages 1417-1427 | Received 29 Sep 2011, Accepted 20 Dec 2011, Published online: 07 Feb 2012

References

  • Draget KI, Smidsrød O, Skjåk-Bræk G. (2005). In Alginates from algae. A Steinbüchel SK, Rhee (eds.), Polysaccharides and polyamides in the food industry: Properties, production and patents (pp. 1–30)), Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA.
  • George M, Abraham TE. (2006). Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan–a review. J Control Release, 114:1–14.
  • Sriamornsak P, Nunthanid J, Luangtana-anan M, Puttipipatkhachorn S. (2007). Alginate-based pellets prepared by extrusion/spheronization: A preliminary study on the effect of additive in granulating liquid. Eur J Pharm Biopharm, 67:227–235.
  • Sriamornsak P, Nunthanid J, Luangtana-anan M, Weerapol Y, Puttipipatkhachorn S. (2008). Alginate-based pellets prepared by extrusion/spheronization: Effect of the amount and type of sodium alginate and calcium salts. Eur J Pharm Biopharm, 69:274–284.
  • Nurulaini H, Wong TW. (2011). Design of in situ dispersible and calcium cross-linked alginate pellets as intestinal-specific drug carrier by melt pelletization technique. J Pharm Sci, 100:2248–2257.
  • Al-Zoubi NM, AlKhatib HS, Obeidat WM. (2011). Evaluation of hydrophilic matrix tablets based on Carbopol(®) 971P and low-viscosity sodium alginate for pH-independent controlled drug release. Drug Dev Ind Pharm, 37:798–808.
  • El-Sherbiny IM, Salama A, Sarhan AA. (2011). Ionotropically cross-linked pH-sensitive IPN hydrogel matrices as potential carriers for intestine-specific oral delivery of protein drugs. Drug Dev Ind Pharm, 37:121–130.
  • Moroni A, Drefko W, Thone G. (2011). Formulations of zero-order, pH-dependent, sustained release matrix systems by ionotropic gelation of alginate-containing mixtures. Drug Dev Ind Pharm, 37:216–224.
  • Itoh K, Tsuruya R, Shimoyama T, Watanabe H, Miyazaki S, D’Emanuele A et al. (2010). In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients. Drug Dev Ind Pharm, 36:449–455.
  • Tapia C, Ormazabal V, Costa E, Yazdani-Pedram M. (2007). Study of dissolution behavior of matrices tablets based on alginate-gelatin mixtures as prolonged diltiazem hydrochloride release systems. Drug Dev Ind Pharm, 33:585–593.
  • Moustafine RI, Salachova AR, Frolova ES, Kemenova VA, Van den Mooter G. (2009). Interpolyelectrolyte complexes of Eudragit E PO with sodium alginate as potential carriers for colonic drug delivery: Monitoring of structural transformation and composition changes during swellability and release evaluating. Drug Dev Ind Pharm, 35:1439–1451.
  • Zeng WM. (2004). Oral controlled release formulation for highly water-soluble drugs: Drug–sodium alginate–xanthan gum–zinc acetate matrix. Drug Dev Ind Pharm, 30:491–495.
  • Setty CM, Sahoo SS, Sa B. (2005). Alginate-coated alginate-polyethyleneimine beads for prolonged release of furosemide in simulated intestinal fluid. Drug Dev Ind Pharm, 31:435–446.
  • Fu Lu M, Woodward L, Borodkin S. (1991). Xanthan gum and alginate based controlled release theophylline formulations. Drug Dev Ind Pharm, 17:1987–2004.
  • Kulkarni AR, Soppimath KS, Aralaguppi MI, Aminabhavi TM, Rudzinski WE. (2000). Preparation of cross-linked sodium alginate microparticles using glutaraldehyde in methanol. Drug Dev Ind Pharm, 26:1121–1124.
  • Cardot J-M, Subirade M, Alric M, Beyssac E. (2009). Investigation of coated whey protein/alginate beads as sustained release dosage form in simulated gastrointestinal environment. Drug Dev Ind Pharm, 35:1103–1112.
  • Erdinc B, Neufeld RJ. (2011). Protein micro and nanoencapsulation within glycol-chitosan/Ca2+/alginate matrix by spray drying. Drug Dev Ind Pharm, 37:619–627.
  • Liu HJ, Li P, Wei Q. (2010). Magnetic N-succinyl chitosan/alginate beads for carbamazepine delivery. Drug Dev Ind Pharm, 36:1286–1294.
  • Wong TW. (2009). Chitosan and its use in design of insulin delivery system. Recent Pat Drug Deliv Formul, 3:8–25.
  • Suknuntha K, Tantishaiyakul V, Worakul N, Taweepreda W. (2011). Characterization of muco- and bioadhesive properties of chitosan, PVP, and chitosan/PVP blends and release of amoxicillin from alginate beads coated with chitosan/PVP. Drug Dev Ind Pharm, 37:408–418.
  • Anal AK, Bhopatkar D, Tokura S, Tamura H, Stevens WF. (2003). Chitosan-alginate multilayer beads for gastric passage and controlled intestinal release of protein. Drug Dev Ind Pharm, 29:713–724.
  • Tapia C, Costa E, Moris M, Sapag-Hagar J, Valenzuela F, Basualto C. (2002). Study of the influence of the pH media dissolution, degree of polymerization, and degree of swelling of the polymers on the mechanism of release of diltiazem from matrices based on mixtures of chitosan/alginate. Drug Dev Ind Pharm, 28:217–224.
  • Coppi G, Iannuccelli V, Leo E, Bernabei MT, Cameroni R. (2001). Chitosan-alginate microparticles as a protein carrier. Drug Dev Ind Pharm, 27:393–400.
  • González-Rodríguez ML, Holgado MA, Sánchez-Lafuente C, Rabasco AM, Fini A. (2002). Alginate/chitosan particulate systems for sodium diclofenac release. Int J Pharm, 232:225–234.
  • Hiorth M, Skøien T, Sande SA. (2010). Immersion coating of pellet cores consisting of chitosan and calcium intended for colon drug delivery. Eur J Pharm Biopharm, 75:245–253.
  • Lucinda-Silva RM, Salgado HRN, Evangelista RC. (2010). Alginate–chitosan systems: In vitro controlled release of triamcinolone and in vivo gastrointestinal transit. Carbohyd Polym, 81:260–268.
  • Chatchawalsaisin J, Podczeck F, Newton JM. (2004). The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation. Int J Pharm, 275:41–60.
  • Steckel H, Mindermann-Nogly F. (2004). Production of chitosan pellets by extrusion/spheronization. Eur J Pharm Biopharm, 57:107–114.
  • Wong TW, Cheong WS, Heng PWS. (2005). Melt granulation and pelletization. In Parikh DM (Ed.), Handbook of pharmaceutical granulation technology (pp. 385–406). New York, USA: Marcel Dekker.
  • United States Pharmacopoeia 32. (2009). Delayed release dosage forms in National Formulary 27 (p. 269). Baltimore, MD: United Book Press.
  • Wong TW, Wahab S, Anthony Y. (2007). Effects of microwave on drug release property of poly(methyl vinyl ether-co-maleic acid) matrix. Drug Dev Ind Pharm, 33:737–746.
  • Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123–133.
  • Zakaria Z, Wong TW. (2009). Chitosan spheroids with microwave modulated drug release. Prog Electromagn Res, 99:355–382.
  • Helgerud T, Gaserød O, Fjæreide T, Anderson PO, Larsen CK. (2010). Alginates. In Imeson A. (ed.), Food stabilizers, thickeners and gelling agents (pp. 50–71). United Kingdom: Blackwell Publishing Ltd.
  • Paños I, Acosta N, Heras A. (2008). New drug delivery systems based on chitosan. Curr Drug Discov Technol, 5:333–341.
  • Lee CC, Ong CL, Heng PW, Chan LW, Wong TW. (2008). Interactive mixture as a rapid drug delivery system. Drug Dev Ind Pharm, 34:206–214.
  • Omwancha W, Kouba C, Yelamanchili S, Neau SH. (2011). Colon-specific drug delivery using ethylcellulose and chitosan in the coat of compression-coated tablets. Drug Dev Ind Pharm, 37:945–953.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.